Aging
Navigate
Submit an Article
Research Paper|Volume 12, Issue 13|pp. 13281–13296
SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer
Back to articleFigure 2(2 of 9)
100%
Figure 2
Figure 2.(A–R) mRNA expression levels of SLC family members in ovarian cancer (426 samples) and normal ovarian tissues (88 samples) (GEPIA). *P < 0.01. SLC, solute carrier.